NEW YORK (GenomeWeb) – OncoDNA said today that it has entered into a new collaboration agreement with Mexican firm Zogen.
Under the deal, Zogen will market and promote OncoDNA's products to oncologists and their patients in Mexico. This includes molecular profiling of both liquid biopsies and solid tumor tissue to guide personalized medicine.
In addition to its tissue and blood-based genomic testing services, OncoDNA also offers software for data interpretation and reporting, all of which is shared with ordering oncologists via an online platform called OncoShare, which the firm said now interfaces with more than 250 hospitals in 60 countries.
Zogen Managing Director Marcel Peguero said in a statement that the new offering is expected to help oncologists in Mexico make better decisions and recommend the latest treatments for patients with metastatic cancer.
Additional terms of the deal were not disclosed.